Healthtech News – Sama Al-Naser

How AI-Powered Wearables are Reshaping Health Care Washington D C. & Maryland Area Capitol Technology University

سما النصر — Mon, 13 Apr 2026 16:11:55 +0000

Finally, the PDMS stamp is placed on a biodegradable PU film, heated to 60 °C for 3 min, cooled to 0 °C for 3 min, and the GNP is transferred to the PU film. Additionally, wearables can send medication reminders and offer personalized health insights, fostering a sense of control and ownership over one’s well-being. This increased engagement empowers patients to make informed decisions about their health and become active partners in their healthcare journey.

Do Wearable Healthcare Devices Require FDA Approval?

A structural abnormality, which hinders heart from not pumping sufficient blood to fulfill the needs of the body, heart failure affects about 26 million people globally45. Heart failure requires real time, continuous monitoring, which increases the economic burden; HWDs can facilitate the daily monitoring of such patients. A number of HWDs have been reported that go beyond diagnosing or monitoring heart failure but can predict it days before it even occurs31,44,46,47,48. Hafid et al. proposed a wearable system to predict heart failure using multiple parameters, such as thoracic impedance, heart rate, ECG, and blood oxygen level48. All of these parameters are measured noninvasively using electronic circuitry, a schematic of which is shown in Fig. The most important parameter may be the thoracic impedance, which is the measure of the resistance to the flow of ions due to the retention of fluid in the thoracic region of the human body49.

The Challenges of Wearables in Healthcare

This wrist-worn device uses oscillometric technology to measure blood pressure accurately and conveniently, making regular monitoring easier than ever. It also tracks physical activity and sleep, providing a comprehensive overview of overall health. These medical devices can enable personalized and continuous monitoring of vital signs, allowing for tailored healthcare solutions. By understanding an individual’s unique health profile, healthcare providers can provide more effective and efficient care. The advent of wearable technology in healthcare has made remote patient monitoring a reality.

In one study, only a few participants recognized specific behavior changes arising from the use of wearables 71. These participants were more disciplined and conscious about activity levels and which exercises were more effective 71. Although only a few commented on any behavior changes, the subjective nature of these changes may mean that others made similar progress but did not recognize such progress.

Applications

That suggests a pragmatic approach to decentralised healthcare in an equitable manner. Considering the growing market of patients with diabetes, a number of HWDs have been introduced for the continuous monitoring of glucose. Notable CGMs are Dexcom G6, Abbott’s FreeStyle Libre System, and Medtronic Guardian Connect123,124,125. With an automatic applicator, the sensor wire is inserted just under the skin of wearer where sensor measures the glucose readings.

The limitations were difficulty translating intervention content to the different contexts of workplaces and ensuring device utilization and compliance with the intervention 160.
The researcher found high compliance and acceptability of the system, and more importantly, the system facilitated timely medical interventions.
Battery life may also pose a challenge, as sustained use is difficult if devices must be charged at least once a day.
Users comparing their own data against expected standards may prompt positive behavior change 82, as not meeting such standards may lead to discomfort, referred to as cognitive dissonance 80.

They count your steps, tell you how far you’ve walked, and even show how many calories you’ve burned. By closely monitoring your heart’s health, you can take measures to improve your cardiovascular well-being and lead a healthier life. With this in mind, in this listicle, we chose to highlight the best health wearable monitoring devices, to get to know the companies leading the way in this sector. Apple has continued its efforts to enhance the Apple Watch’s healthcare capabilities, adding atrial fibrillation history recording and medication tracking capabilities in 2022 and a new sleep apnea feature in 2024. Sensate wearable tech, which uses patented infrasonic technology, claims to diminish stress, anxiety, and insomnia.

AI Smart Glasses and Augmented Reality Wearables

Even companies have adopted wearables to encourage healthy habits among office workers and employees working from home. These devices are used mainly in health and safety monitoring 25, chronic disease management 26, disease diagnosis and treatment 27, and rehabilitation 28. We predict that with https://chinanews777.com/sterile-processing-technician-vs-surgical-technologist-whats-the-difference.html the development of science and technology and the popularization of personalized health concepts, wearable devices will play a greater role in the field of health care and become better integrated into people’s daily lives.

As technology and electronics evolve, getting smaller and more powerful, tech companies are continuously developing devices that are easily worn but can provide a wealth of patient health data. These innovative tools make vast improvements to healthcare outcomes, allowing a more granular https://canadatc.com/the-unsung-hero-of-dentistry-tools-why-contra-angle-handpieces-are-essential.html look at a patient’s vitals and facilitating more patient engagement in their own health. If HIT systems can keep up with wearable health devices to collect the right real-time medical data, those relevant patient insights could be critical for physicians.

Market Research Reports

For some users, this focus on rewards or social comparison may only appear detrimental to their physical activity in the long term 69 and may not be reflected in the findings of relatively short studies. Users seem to appreciate that consumer wearables are not medically accurate devices and that clinicians would not solely rely on data from such devices to make clinical decisions 84. An open-minded, supportive approach may encourage patients to share data with their clinicians 84. However, clinicians who are unwilling to engage with wearables and support their empowered patients, on the grounds of potential inaccuracies regarding data 84, may risk foregoing the benefits attributable to wearables. Collaboration between research management and health care staff is imperative, especially during the study design process, as such a partnership may benefit patient compliance, particularly for those with cognitive impairments 65.

Fitness trackers are devices that monitor physical activity, steps, calories burned, and sleep. They provide users with valuable insights into their daily habits and can motivate them to make healthier choices. In addition, Lee et al. assessed the efficacy of MAVE®, a neurofeedback wearable device, in stress alleviation via meditation.

The Importance of Wearable Health Monitoring Devices in Transforming Healthcare

Any minimally invasive device that is worn on the body to collect, analyze, and transmit health data is a wearable medical device. The most common examples are consumer-grade fitness trackers that monitor heart rates and other exercise-related data. Medical-grade systems approved for clinical use can also track more specific health vitals, such as glucose, blood pressure, and other condition-specific markers.

The Top 10 Healthcare Technology Trends for 2025

سما النصر — Tue, 04 Feb 2025 14:32:19 +0000

Forbes reports that a leak of Anthropic’s Claude code components has legitimized neuro-symbolic AI as a potential future direction for artificial intelligence development. This hybrid approach combines conventional neural networks (subsymbolic AI) with rules-based expert systems (symbolic AI), aiming to get the best of both data-driven and logic-based AI approaches. The demand for IVD is growing rapidly due to chronic disease management, and rapid diagnostic test kits can help with quick diagnosis and reduction in complications.

Digitalisation in healthcare

RFID – the same wireless technology that can track pets or locate items – can also be used to measure breathing in patients with impaired lung function contactlessly – in hospital or at home. By combining two specific markers from a standard cardiac CT scan, researchers were able to identify patients at the highest risk for future heart failure and death. New models help identify cardiovascular disease risk even before symptoms appear. The researcher’s findings also indicate that the risk of heart failure is not evenly distributed across Europe. The research shows this protective behavior occurs with “alarming frequency” across all tested models. New research reveals that marketers are successfully manipulating AI search responses through strategic creation of self-serving listicles and recommendation content.

Advancing healthcare with data interoperability and standardization

Now switching resembles pilots moving from Boeing jets to Airbus jets—it’s possible but increasingly difficult. This also raises barriers to entry because a new entrant needs not just a great implant but also a robotic system to implant it. The company combines nanotechnology with AI algorithms to capture and interpret physiological signals related to pain.

Future of Healthcare: Nanotech, Wearables, and Telemedicine

In vitro diagnostics (IVD) was the leading segment of medical technology globally, making up almost a fifth of the total market. In vitro refers to any tests that diagnose and detect diseases, infections, and other conditions. IVD can range from very simple devices that a person could use in their own homes to very complex instruments used in a laboratory. The IVD market was forecast to increase to over 188 billion U.S. dollars by 2030.

Augmented Medical Education and Decision-making Healthcare Digital Trends

In the United States, Deloitte refers to one or more of the US member firms of DTTL, their related entities that operate using the “Deloitte” name in the United States and their respective affiliates.
Circular economy models, supported by digital tools, are also becoming more common.
These platforms facilitate the real-time flow of information vital for reducing risk, improving compliance, and enhancing patient care.
In fact, reducing these Scope 3 emissions is expected to have seven times more impact than just lowering a company’s own emissions.
The Internet of Medical Things is transitioning from the early adopter phase to mainstream deployment across hospitals, home care and consumer health.

They will leverage surgical robotics strategically or find differentiated niches without robotics dependence. They will apply AI where it delivers genuine operational value rather than focusing exclusively on adding it to the medtech product. They will maintain flexibility through active scenario planning, and they will deliberately align device strategies with pharmaceutical innovations reshaping care pathways. Food and Drug Administration applications of AI in medtech products shows often small companies, not industry titans, who are winning most of the approvals. Hard to succeed, narrowly confined in radiology and cardiology, diagnostic in nature and somewhat difficult to monetize are all reasons to be thoughtful in an AI strategy. That’s not to write off AI in medtech products, just to be realistic about the business model.

As healthcare facilities rapidly embraced new technologies to meet the challenges of the COVID-19 pandemic, cybersecurity upgrades have often lagged, leaving many organizations vulnerable. In today’s digital era, AI-generated fake media poses significant challenges, especially in health care, by distorting information and compromising data integrity. Health providers must consider defending against misinformation to maintain patient trust and care integrity. This issue highlights the importance of robust cyber defenses and sophisticated detection methods.

Artificial intelligence

This represents a significant advance in physical AI models, which have lagged behind language models due to the difficulty of collecting training data for real-world manipulation tasks.
They are becoming popular and widespread in every industry, including healthcare and medical consulting.
The optimism of early 2026 is now being tested against operational reality — deployments that looked promising in Q1 are delivering their first honest results, and the gap between demo and production continues to define winners and losers.
Our expertise spans smart contracts, decentralized apps, asset tokenization, and interoperability solutions tailored to meet your unique industry needs.
CRISPR continues to evolve with prime and base editing, correcting up to 90% of disease-causing mutations.

Internal communication platforms play a critical role in supporting automation initiatives. By integrating these platforms with automated https://strikeforceheroes4.com/is-technology-destroying-communication.html systems, professionals can receive real-time notifications about important tasks, policy updates, or patient-specific information. This integration ensures that staff stay informed and can respond promptly to any administrative issues that arise, further reducing risk.

Over a billion people living with mental health conditions services require urgent scale-up

سما النصر — Mon, 20 Nov 2023 08:01:43 +0000

In the past year clinicians have shown increasing receptivity to AI-enabled clinical functions, in part because their exposure to administrative solutions has increased their comfort with—and even outright enthusiasm for—the potential of AI more generally. These trends might seem surprising at first glance, given that the general industry commentary suggests that provider margins finally started to stabilize in 2023, and improved even further across 2024. This material (including market commentary, market data, observations or the like) has been prepared by personnel in the Investment Banking Group of JPMorgan Chase & Co. and/or its affiliates and subsidiaries worldwide (“J.P. Morgan”). It has not been reviewed, endorsed or otherwise approved by, and is not a https://dublindecor.net/plants/how-sterile-processing-technicians-impact-patient-safety-in-hospitals.html work product of, any research department of J.P.

To navigate these regulatory landscapes, PE firms often employ Management Services Organizations (MSOs). The MSO, owned by the PE firm, manages non-legal functions such as marketing and administration, while the law firm retains control over legal services. This structure enables compliance with ownership regulations while allowing PE firms to invest in the business aspects of law practices.

Investment Opportunities in the Georgian Medical Sector

Looking ahead to 2026, take-privates are poised to be a meaningful, and potentially growing, part of the deal mix. The combination of elevated public indices, uneven multiple expansion, and continued portfolio simplification may underpin activity. This activity is likely to be selective rather than broad-based, concentrated in segments where operational turnarounds, carve-outs, or digital enablement can materially shift earnings trajectories. With the hope of better economic conditions as well as reduced headwinds for many subsectors, respondents to our survey said they are looking forward to increased M&A in 2025.

Stay ahead of markets with the latest insights from the BlackRock Investment Institute.

It represents an investment arbitrage opportunity because it has historically been underinvested across private equity, venture capital, and pharma. The macroeconomic climate improved last year, seemingly setting the stage for a more productive HCLS M&A marketplace. Inflation declined, leading to an anticipation of interest rate cuts by the US Federal Reserve that then began with a large, 50-basis-point reduction in September. Consumers continued to spend, unemployment remained low, and the US avoided the recession that many economists had forecast. As portfolio optimisation continues and next-generation technologies scale, we expect medtech deal activity in 2026 to remain robust.

The sector continues to benefit from demographic tailwinds and the shift to outpatient and home-based care.
We explore how capital, data and risk are driving the next phase of the transition.
In the past year clinicians have shown increasing receptivity to AI-enabled clinical functions, in part because their exposure to administrative solutions has increased their comfort with—and even outright enthusiasm for—the potential of AI more generally.
The breakthrough demonstrates robots successfully completing fiddly tasks that many humans struggle with, such as drawing cash from a wallet and reinserting it, or carefully stacking oranges in neat pyramids.
The cookie will expire after six months, or sooner should there be a material change to this important information.

Over a billion people living with mental health conditions – services require urgent scale-up

Ambulatory and post-acute services are expected to drive healthcare sector volume growth in 2026, fueled by cost pressures, an aging population, advances in therapy and value-based care.
Technology-enabled services that have developed unique or market-leading platforms are particularly attractive.
Another possible byproduct of MFN would be more splits-rights deals, in which a company licenses EU or emerging-market rights to a partner, which could insulate U.S. pricing from downward pressure.
Annual revenue from drugs originating in China could soar to $34 billion by 2030 and $220 billion by 2040, according to Morgan Stanley Research.
As the two major commercialized innovators, Novo and Eli Lilly, drove very strong growth , companies across the supply chain positioned themselves to capitalize on the growth opportunities.

Biotech, however, remains uneven, and while public markets are opening for late-stage, data-rich, and derisked assets, much of the earlier-stage cohort remains constrained. M&A remains the fastest and most effective way to modernise operations, accelerate scientific and digital innovation, and build the capabilities required for prevention-led, personalised, and care-anywhere models. The deals that stand out will be those backed by differentiated data http://www.portobellocc.org/pccpn/2016/02/19/public-meetings-notice-review-of-childrens-hospital-services/ and evidence-backed innovation, AI-enhanced productivity, and clear pathways to long-term value creation.

Healthcare leaders have key growth opportunities in 2026 despite the mounting pressures that are reshaping the industry.
New research reveals that marketers are successfully manipulating AI search responses through strategic creation of self-serving listicles and recommendation content.
And provider and biopharma anchored activity while healthcare IT continued to grow its share of healthcare transaction volume.
Even so, drugmakers targeting global markets said they cannot rely on Chinese patient recruitment alone.

The firm’s bankers also spoke about how an M&A rebound could further accelerate the resurgence in IPOs. In 2024, healthcare composed 20% of total IPO volume and had the greatest number by sector. Healthcare IPOs are gaining momentum mostly in therapeutics, diagnostics and MedTech.

Life sciences dealmaking looks east

Erdei spearheaded the organization of Jefferies’ annual Global Healthcare Conference and hosts the annual Healthcare Temperature Check. Understanding how these forces interact is essential for navigating the year ahead. Get the insights that matter — grounded in data, shaped by research and focused on the themes that will define 2026. Pratik Desai, a 34-year-old technologist, developed an AI-assisted workflow in early 2026 to help manage his mother’s Stage 4 duodenal adenocarcinoma care. The system ingested daily Epic medical record exports into NotebookLM and Claude, enabling him to spot CAT-scan misdiagnoses, detect medical emergencies, and coordinate care more effectively than traditional methods. Google has fully integrated NotebookLM, its AI-powered research assistant, directly into the Gemini chatbot interface, allowing users to create research notebooks without switching between applications.

How are healthcare investors thinking about value creation over the next decade?

You acknowledge that certain information contained in this Website supplied by third parties may be incorrect or incomplete, and such information is provided on an “AS IS” basis. We reserve the right to change, modify, add, or delete, any content and the terms of use of this Website without notice. Users are advised to periodically review the contents of this Website to be familiar with any modifications.

Healthcare services: Care anywhere, scale everywhere

Despite making its LLaMA models open source and aggressively promoting AI features across its platforms, Meta has seen minimal user engagement with its AI products compared to competitors like OpenAI and Google. METATRON joins other recent AI security tools like Apex, an autonomous AI-powered penetration testing agent, and follows Kali Linux’s official integration of Claude AI for penetration testing via Model Context Protocol. These developments highlight the rapid adoption of AI in cybersecurity, where automated vulnerability discovery and threat analysis are becoming increasingly sophisticated and accessible to security professionals.

The integration represents a shift in the traditional workflow from brand → human research → marketplace → publisher to brand → AI agent → marketplace → publisher. This automation allows AI assistants to connect to marketplaces, assemble options, map them to formats and KPIs, with human teams only stepping in for strategy refinement and partnership negotiations. Anthropic has significantly expanded its compute agreement with Google and Broadcom amid exploding demand for Claude models, particularly from enterprise customers. The company’s revenue run rate has skyrocketed to $30 billion, marking a dramatic jump from $9 billion recorded at the end of 2025, despite being labeled a supply chain risk by the U.S.

Lau noted that global pharma will guide the way on dealmaking, and that markets with predictable regulation and stable interest rates will see the most activity. “The future will reward those who can execute efficiently and build trust-based, long-term relationships, especially as global competition for innovative assets intensifies,” he said. Drugmakers said they are exploring direct-to-consumer (DTC) models as a lever to lower costs while broadening access. This approach may be most viable for drugs including those for HIV and diabetes, oral GLP-1s and respiratory or inhaled medicines, compared to high-cost branded therapies that require complex financing. DTC models also align with cash-pay channels, and options for patients to secure lower prices by committing to longer treatment durations.